maprotiline has been researched along with Chronic Kidney Failure in 2 studies
Maprotiline: A bridged-ring tetracyclic antidepressant that is both mechanistically and functionally similar to the tricyclic antidepressants, including side effects associated with its use.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukunishi, I | 1 |
| Kitaoka, T | 1 |
| Shirai, T | 1 |
| Watanabe, S | 1 |
| Kennedy, SH | 1 |
| Craven, JL | 1 |
| Rodin, GM | 1 |
| Roin, GM | 1 |
1 trial available for maprotiline and Chronic Kidney Failure
| Article | Year |
|---|---|
Major depression in renal dialysis patients: an open trial of antidepressant therapy.
Topics: Aged; Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder; Desipramine; Humans; Kid | 1989 |
1 other study available for maprotiline and Chronic Kidney Failure
| Article | Year |
|---|---|
Cardiac arrest caused by maprotiline in an elderly hemodialysis patient.
Topics: Aged; Antidepressive Agents, Tricyclic; Female; Heart Arrest; Humans; Kidney Failure, Chronic; Mapro | 1998 |